These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11501614)

  • 1. Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation?
    Michel MC; Schafers RF; Goepel M
    BJU Int; 2000 Oct; 86 Suppl 2():23-8; discussion 28-30. PubMed ID: 11501614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH.
    de Mey C
    Eur Urol; 1998; 34 Suppl 2():18-28; discusion 47. PubMed ID: 9732829
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 5. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-adrenergic blocking drugs in bladder outflow obstruction: what potential has alpha 1-adrenoceptor selectivity?
    Chapple CR
    Br J Urol; 1995 Jul; 76 Suppl 1():47-55. PubMed ID: 7544214
    [No Abstract]   [Full Text] [Related]  

  • 7. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of alpha blockers in BPH.
    Jardin A
    Prog Clin Biol Res; 1994; 386():279-83. PubMed ID: 7528395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
    Kondo A; Narita H; Otani T; Kobayashi M; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1232-40. PubMed ID: 83419
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha adrenoceptor antagonists in the year 2000: is there anything new?
    Chapple CR
    Curr Opin Urol; 2001 Jan; 11(1):9-16. PubMed ID: 11148741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.
    Schwinn DA
    BJU Int; 2001 Sep; 88 Suppl 2():27-34; discussion 49-50. PubMed ID: 11589667
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of terazosin on clinical benign prostatic hyperplasia in older adults.
    Mudiyala R; Ahmed A
    J Am Geriatr Soc; 2003 Mar; 51(3):424-6. PubMed ID: 12588590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
    Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 16. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Benign prostate hyperplasia: success and limitations of pharmacological therapy].
    Madersbacher S; Marszalek M
    Internist (Berl); 2007 Oct; 48(10):1157-64. PubMed ID: 17426942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relaxant effect of ginseng saponin on the bladder and prostatic urethra: an in vitro and in vivo study.
    Jang HA; Cho S; Kang SG; Ko YH; Kang SH; Bae JH; Cheon J; Kim JJ; Lee JG
    Urol Int; 2012; 88(4):463-9. PubMed ID: 22507987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?
    Michel MC
    J Pharmacol Sci; 2010; 112(2):151-7. PubMed ID: 20134112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.